- New Leaf Ventures (NLV) is strengthening its CBD product line, Dama, with the launch of all-new products on its website
- Dama products come with all the benefits of high grade, full-spectrum hemp oil but without the psychoactive properties of THC
- The line includes gummies, tinctures, and capsules
- New Leaf Ventures Inc is a licensed producer and processor of ultra-premium cannabis
- New Leaf Ventures (NLV) is currently down 2.27 per cent on the day, trading at $0.43 per share
New Leaf Ventures (NLV) is strengthening its CBD product line, Dama, with the launch of all-new products on its website.
The company recently announced that it plans to rebrand the flagship product line, which includes gummies, tinctures, and capsules in various doses.
The all-new products are based on advanced plant science and the same high standards as the rest of the company’s Dama products.
Dama products come with all the benefits of high-grade, full-spectrum hemp oil but without the psychoactive properties of THC.
Robert (Dax) Colwell, CEO and co-founder of New Leaf USA, commented on the release of the new products.
“Over the years, Dama has upheld the rich heritage of the plant and ongoing research through superior cultivation methodology and innovation in all our concentrate products,” he said.
“Today, Dama is known by our customers to produce consistently clean, potent, and pure products, and now we can offer the benefits of hemp-based, non-psychoactive, CBD-rich formulations to a significantly larger consumer base across most of the nation.”
New Leaf Ventures Inc is a licensed producer and processor of ultra-premium cannabis.
The company’s flagship enterprise is New Leaf USA and its subsidiaries, which provide licenses, consulting services, real property, intellectual property and equipment.
New Leaf Ventures (NLV) is currently down 2.27 per cent on the day, trading at $0.43 per share as of 11:51 am ET.